Mount Sinai Health System Receives 2024 CHIME Digital Health Most Wired Recognition

Award honors health organizations that successfully drive meaningful change through digital transformation

Mount Sinai Researchers Have Uncovered the Mechanism in the Brain That Constantly Refreshes Memory

Mount Sinai researchers have discovered for the first time a neural mechanism for memory integration that stretches across both time and personal experience.

Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, Study Finds

First-of-its kind work led by Mount Sinai researcher supports reserving this technique for extreme cases

Mount Sinai Doctors to Present at ID Week 2024

Experts in infection prevention and control available for interview about research findings and other breaking health topics including the flu, COVID, HIV, mpox, West Nile, and vaccinations

Mount Sinai Opens State-of-the-Art Center for Patients With Complex Conditions Including Lyme Disease and Long COVID

The Cohen Center for Recovery From Complex Chronic Illnesses will also research new therapies for these conditions

Mount Sinai BioDesign Expands Industry Collaborations to Expedite and Enhance the Development of Innovative Surgical Technologies

Mount Sinai Health System today announced that Mount Sinai BioDesign, the medical technology incubator of the Health System, has expanded its reach to become a key, effective partner for the broader MedTech community.

Mount Sinai Leaders Receive Prestigious Awards During the American College of Emergency Physicians 2024 Scientific Assembly (ACEP24)

CEO of the Mount Sinai Health System and Chair of the Emergency Department for Mount Sinai Queens will be honored for their contributions to health policy and diversity, inclusion, and health equity

Presence of Subclinical Atherosclerosis Is Marker of Mortality and Its Progression Increases Risk of Death

Mount Sinai study also shows imaging for early detection and monitoring can improve prediction and prevention of premature death

UNDER EMBARGO: Mount Sinai Study Identifies Link Between Prediabetes During Adolescence and Young Adulthood With the Likelihood of Adverse Pregnancy Outcomes

New paper finds that prediabetes before conception may significantly increase the likelihood of gestational diabetes during first pregnancy

Mount Sinai Health System and IBM Research Launch Effort That Leverages Artificial Intelligence and Behavioral Data to Improve Mental Health Care for Young People

Mount Sinai Health System and IBM Research today announced the launch of the Phenotypes Reimagined to Define Clinical Treatment and Outcome Research (PREDiCTOR) study. The research effort aims to address the lack of objective measures in psychiatry by leveraging advances in artificial intelligence and incorporating rich behavioral data from clinical interviews, at-home data captured on smartphones, and cognitive testing.

Richard Rosen, MD, Receives Prestigious Award From the American Society of Retina Specialists (ASRS)

The American Society of Retina Specialists is honoring Richard B. Rosen, MD, ScD (hon), FACS, FASRS, FARVO, CRA, the Belinda Bingham Pierce and Gerald G. Pierce Distinguished Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, with the prestigious Founders Award for 2024.

Pulsed Field Ablation Procedures Found Safe and Effective for Atrial Fibrillation Patients

Mount Sinai-led study demonstrates significant safety outcomes and could lead to more frequent use of this new technology

Mount Sinai Expands Center for Post-COVID Care to Serve Patients in East Harlem and South Bronx

$5 million grant from the Agency for Healthcare Research and Quality will enhance long COVID care for underserved minority groups, community outreach, and research

Benjamin S. Abella, MD, MPhil, Named as Chair of the Department of Emergency Medicine for the Mount Sinai Health System

Benjamin S. Abella, MD, MPhil, a national leader in the study of sudden cardiac arrest and cardiopulmonary resuscitation (CPR), has been appointed Chair of the Department of Emergency Medicine for the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System.

Valentin Fuster, MD, PhD, Received 2024 Distinguished Award From European Society for Clinical Investigation (ESCI)

President of Mount Sinai Fuster Heart Hospital given top honor for his scientific excellence and successful global education initiatives on cardiovascular disease

RNA Inhibitor Is Shown Safe and Effective in Reducing a Wide Range of Cholesterol and Triglyceride Levels in the Blood in Mount Sinai-Led Clinical Trial

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.

Two New Studies by Mount Sinai Researchers in Science Offer Key Insights Into the Origins and Potential Treatment of Mental Health Disorders

Working under the umbrella of the PsychENCODE Consortium, the mental health research project established in 2015 by the National Institutes of Health, a team of Mount Sinai scientists has uncovered important new insights into the molecular biology of neuropsychiatric disease through two new studies published in a special issue of Science on Friday, May 24.

Mount Sinai Experts to Present New Research on Long COVID, Lung Cancer, Asthma, Sleep Apnea, and More at ATS 2024 International Conference

Available for interview on breaking news, trending topics in respiratory medicine

Mount Sinai Experts to Present New Research on Preeclampsia, Preterm Birth, Doula Care and More at the 2024 ACOG Annual Clinical and Scientific Meeting

Women’s health doctors and researchers will share new insights on prenatal care

Mount Sinai’s Yvette Calderon, MD, MS, Receives Prestigious Award From Society for Academic Emergency Medicine

Top honor recognizes her commitment to justice, equity, diversity, and inclusion through scholarship, mentorship, and leadership

Mount Sinai Experts Available for Interview During Women’s Health Awareness Month

  Mount Sinai Experts Available for Interview During Women’s Health Awareness Month  As we continue to recognize May as Women’s Health Awareness Month, and kick off National Women’s Health Week on Sunday, May 12, I want to flag Mount Sinai…

Mount Sinai Scientists Unravel How Psychedelic Drugs Interact with Serotonin Receptors to Potentially Produce Therapeutic Benefits

Researchers at the Icahn School of Medicine at Mount Sinai have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatric disorders such as depression and anxiety.

A Common Pathway in the Brain That Enables Addictive Drugs to Hijack Natural Reward Processing Has Been Identified by Mount Sinai

Mount Sinai researchers, in collaboration with scientists at The Rockefeller University, have uncovered a mechanism in the brain that allows cocaine and morphine to take over natural reward processing systems.

Mount Sinai Study Calls for Major Changes in the Way People With Comorbidities Are Selected by Physicians for Lung Cancer Screening

A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients on whether to proceed with lung cancer screening is fraught with confusion and lack of evidence-based information, and may actually be undermining the purpose for which it was created, Mount Sinai researchers say.

Mount Sinai Is First in New York to Study a Brain-Computer Interface Designed to Record and Map the Brain’s Activity in Unprecedented Detail

A multidisciplinary team of neurosurgeons and neuroscientists from the Icahn School of Medicine at Mount Sinai are the first in New York to study a new brain-computer interface that’s engineered to map a large area of the brain’s surface, in real time, at resolutions hundreds of times more detailed than typical arrays used in neurosurgical procedures.

Mount Sinai Experts Available for Interview During Endometriosis Awareness Month

Contact: Stacy A. Anderson                     Mount Sinai Press Office                     347-346-3390                     [email protected]                            (New York, NY – March 21, 2024) – As we continue to recognize March as Endometriosis Awareness Month, observed to bring attention to the…

Mount Sinai Doctors to Present New Research at 2024 SMFM Annual Pregnancy Meeting

High-risk pregnancy specialists from the Mount Sinai Health System are presenting research at the Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine (SMFM) from February 10-14

Mount Sinai Ophthalmologists Develop Novel Protocol to Rapidly Diagnose and Treat Eye Stroke

Study shows using advanced technology and time can prevent permanent vision loss

Mount Sinai Researchers Awarded $4.1 Million NIH Grant to Advance Understanding of Sleep Apnea Using Artificial Intelligence

Machine-learning method aims to predict consequences of serious sleep disorder impacting millions in the U.S.

Posterior Wall Ablation Does Not Help Patients With Persistent Atrial Fibrillation

FOR IMMEDIATE RELEASE                  Contact:  Ilana Nikravesh                  Mount Sinai Press Office                  212-241-9200                   [email protected]   …

Researchers Discover Why One Type of Chemotherapy Works Best in Bladder Cancer

Tisch Cancer Institute researchers discovered that a certain type of chemotherapy improves the immune system’s ability to fight off bladder cancer, particularly when combined with immunotherapy, according to a study published in Cell Reports Medicine in January.

Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myeloma Research Foundation

The Mount Sinai Health System has received a $7 million grant from the Multiple Myeloma Research Foundation for a three-year project that aims to fast-track novel translational concepts to improve outcomes for people with high risk myeloma, the second most common blood cancer in the United States.